THE APEX TIMES
A review of 13F filings for the quarter ended Sept. 30 shows 27 major funds reduced holdings of UnitedHealth, including George Soros’ firm, while 12 other large investors increased exposure.
UnitedHealth, one of the largest U.S. health insurers, saw mixed indicates from big institutional investors in the latest round of 13F disclosures covering the quarter ended Sept. 30. According to a tally reported by Yahoo Finance via a data compilation, 460 large funds that filed 13Fs held UnitedHealth shares, with 27 reducing their positions during the quarter and 12 adding to theirs.
The most notable name among the funds that sold was George Soros. The reported review indicates that Soros’ fund was among the 27 sellers in the period, contrasting with buyers that were willing to increase exposure to the stock despite that reduction activity.
The accounting behind the filings is straightforward but important for interpretation. A 13F is a quarterly report filed with regulators that discloses certain equity holdings of large asset managers. It does not capture every trade, the full details of derivatives, or the timing of buy and sell decisions within the quarter. Still, 13F changes provide a useful snapshot of how leading managers were thinking about public stocks at a point in time.
In the quarter summarized in the report, the net picture suggested more selling than buying among the tracked set of large filers. The data set cited 27 sellers compared with 12 buyers, a gap that may reflect differing portfolio strategies across fund managers, risk management around health-care exposure, or company-specific assessments rather than a single unified view of the sector.
The report frames the question as a debate about “who’s right,” but it also underscores the limits of reading intention from quarter-end snapshots. For example, institutional investors can rebalance for liquidity needs, adjust exposure across mandates, or respond to fund-level inflows and outflows, all without implying a directional forecast for the business itself.
UnitedHealth operates across insurance and health services, and for large funds it often sits at the center of health-care-related exposure. As a result, even small shifts in institutional allocations can stand out in headline comparisons, especially when prominent investors such as Soros appear in the sell list.
What the post does not provide are granular details on how large the trims or adds were, whether the trades were incremental or closeouts, or whether the selling was concentrated in one or a few funds. Without that breakdown, it is not possible to determine whether the reductions were material relative to each fund’s overall portfolio or whether they represented minor position adjustments.
Looking ahead, investors and analysts typically watch for follow-through in subsequent filings and for any company-specific updates that might change the investment case, such as guidance on medical cost trends, premium and enrollment dynamics, or performance of key operating segments. The next 13F cycle will be one place to see whether current buyers continue to add, and whether sellers reduce further or reverse course.
Investors moved quickly after early outlines connected United Launch Alliance’s work to the BE-4 engine family, which Blue Origin’s New Glenn is expected to use for a planned 2027 flight carrying AST SpaceMobile’s BlueBird satellites.
A report tied to Anthropic’s debut highlights a cash position large enough to dwarf the combined figures of Amazon and NVIDIA, while also pointing to a new exchange-traded fund built around companies described as “ANT-linked.”
A Yahoo Finance report highlights how Berkshire Hathaway’s roughly $10 billion investment in Alphabet appears to be losing value, with Bill Ackman commenting that the timing and pricing were unexpected even as he noted the stake was bought at a perceived discount.
The company said it has reshaped leadership around national security and export-control oversight after Huang’s exit, emphasizing governance changes ahead of its next quarter and the continuing geopolitical scrutiny on advanced chips.
Anthropic priced its IPO at $83 per share ahead of its debut, while Nvidia heads toward a seventh straight weekly decline amid fresh US pressure on AI chip exports.
A single software issue highlighted weaknesses in payment-related systems, according to a report that described delays affecting Zelle transactions.
The crypto exchange is tied to a move to issue tokenized US stocks on the Base network, raising questions about how onchain share representations could expand access to traditional equities through 24/7 rails.
Goldman Sachs (NYSE:GS) is leading a $280 million round for Payhawk, aiming to expand the startup’s global Finance Operating System that connects payments and spend controls, according to a report citing the deal.
A report citing Cathie Wood’s ARK funds says they sold about $84.8 million of Nvidia shares before the company’s earnings period and used the cash to buy holdings tied to crypto markets.
The change reflects what Berkshire’s latest disclosure says happened to one of its long-running holdings after the company indicated an exit earlier in the year.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...